MetaADEDB 2.0 @ LMMD
balsalazide
(IPOKCKJONYRRHP-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)CCNC(=O)c1ccc(cc1)N=Nc1ccc(c(c1)C(=O)O)O
Type(s)
Approved; Investigational
ATC code(s)
A07EC04
Molecular Formula:
C17H15N3O6
Molecular Weight:
357.317
Log P:
3.1012
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
4
TPSA:
148.65
CAS Number(s):
80573-04-2; 399030-81-0
Synonym(s)
1.
balsalazide
2.
5-(carboxyethylcarbamoyl-4-phenylazo)salicylic acid
3.
BX 661A
4.
BX661A
5.
Colazal
6.
Colazide
7.
balsalazide disodium
8.
balsalazine
External Link(s)
MeSHC038637
PubChem Compound54585
ChEBI267413
94605
CHEMBLCHEMBL1201346
CHEMBL1208641
DrugBankDB01014
DrugCentral284
KEGGdr:D07488
Therapeutic Target DatabaseD0A6KR
ZINC100050064
100056740
3952881
242522365
13863965
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 5OFFSIDES
US FAERS
2NauseaFAERS: 3SIDER
US FAERS
3Product quality issueFAERS: 3US FAERS
4Abdominal discomfortFAERS: 2OFFSIDES
US FAERS
5ArthralgiaFAERS: 2SIDER
US FAERS
6PainFAERS: 2OFFSIDES
SIDER
US FAERS
7Product substitution issueFAERS: 2US FAERS
8Product taste abnormalFAERS: 2US FAERS
9AlopeciaFAERS: 1SIDER
US FAERS
10ColitisFAERS: 119296261CTD
US FAERS
11DiscomfortFAERS: 1SIDER
US FAERS
12DizzinessFAERS: 1SIDER
US FAERS
13FatigueFAERS: 1OFFSIDES
SIDER
US FAERS
14FlatulenceFAERS: 1SIDER
US FAERS
15FlushingFAERS: 1US FAERS
16HeadacheFAERS: 19882028CTD
SIDER
US FAERS
17InfectionFAERS: 1SIDER
US FAERS
18Irritable Bowel SyndromeFAERS: 1US FAERS
19PalpitationsFAERS: 1US FAERS
20Peripheral swellingFAERS: 1US FAERS
21PleuropericarditisFAERS: 1US FAERS
22StomatitisFAERS: 1SIDER
US FAERS
23Therapeutic response unexpected with drug substitutionFAERS: 1OFFSIDES
US FAERS
24TrichorrhexisFAERS: 1US FAERS
25Urinary tract infectionFAERS: 1SIDER
US FAERS
26Weight decreasedFAERS: 1US FAERS
27treatment failureFAERS: 1US FAERS
28Abdominal PainOFFSIDES
SIDER
29Abdominal tendernessOFFSIDES
30Accidental exposureOFFSIDES
31Acute myocardial infarctionOFFSIDES
32Acute respiratory failureOFFSIDES
33AlveolitisSIDER
34AmnesiaOFFSIDES
35AngioedemaOFFSIDES
36AnorexiaSIDER
37Anticoagulation drug level below therapeuticOFFSIDES
38Antiphospholipid SyndromeOFFSIDES
39AnuriaOFFSIDES
40AnxietyOFFSIDES
41Aortic AneurysmOFFSIDES
42AppendicitisOFFSIDES
43ArthritisOFFSIDES
44Aspartate Aminotransferase IncreasedSIDER
45AstheniaOFFSIDES
SIDER
46AsthmaOFFSIDES
47AtherosclerosisOFFSIDES
48Back PainSIDER
49Bipolar DisorderOFFSIDES
50Blood amylase increasedOFFSIDES
51Blood glucose fluctuationOFFSIDES
52Bronchoalveolar lavage abnormalOFFSIDES
53BruxismOFFSIDES
54Chest PainOFFSIDES
55Choking sensationOFFSIDES
56Chronic Fatigue SyndromeOFFSIDES
57Chronic ulcerative colitisOFFSIDES
58Cold sweatOFFSIDES
59Congenital tricuspid valve incompetenceOFFSIDES
60ConstipationSIDER
61DeafnessOFFSIDES
62DermatitisSIDER
63DiarrheaOFFSIDES
64Disease ProgressionOFFSIDES
65Drug dose omissionOFFSIDES
66Drug exposure via breast milkOFFSIDES
67Drug withdrawal headacheOFFSIDES
68DyspepsiaOFFSIDES
SIDER
69DysphemiaOFFSIDES
70Dysthymic DisorderOFFSIDES
71EncephalitisOFFSIDES
72EosinophiliaSIDER
73Eosinophilic PneumoniaOFFSIDES
74Eosinophilic myocarditisOFFSIDES
75Erythema NodosumOFFSIDES
SIDER
76Feeling ColdOFFSIDES
77Feeling abnormalSIDER
78Flight of ideasOFFSIDES
79Fungus culture positiveOFFSIDES
80GastroenteritisSIDER
81Gastrointestinal PainSIDER
82Gastrointestinal obstructionOFFSIDES
83GlobulinuriaOFFSIDES
84Hepatic necrosisSIDER
85HepatotoxicitySIDER
86HistoplasmosisOFFSIDES
87ImmobileOFFSIDES
88Incorrect dose administeredOFFSIDES
89InfestationSIDER
90InfluenzaSIDER
91Infusion site mobility decreasedOFFSIDES
92Injection site erythemaOFFSIDES
93Injection site noduleOFFSIDES
94Injection site vesiclesOFFSIDES
95Intestinal ObstructionOFFSIDES
96Intestinal resectionOFFSIDES
97Kidney FailureOFFSIDES
98LeishmaniasisOFFSIDES
99Lethargy9882028CTD
SIDER
100LipaseOFFSIDES
101Loose toothOFFSIDES
102LymphomaOFFSIDES
103MalaiseSIDER
104Malignant melanoma in situOFFSIDES
105Musculoskeletal PainSIDER
106Musculoskeletal discomfortSIDER
107Musculoskeletal stiffnessOFFSIDES
108MyalgiaSIDER
109Myocarditis17889383CTD
SIDER
110NasopharyngitisSIDER
111OrchitisOFFSIDES
112PancreatitisOFFSIDES
SIDER
113PericarditisSIDER
114PharyngitisSIDER
115Pharyngolaryngeal PainSIDER
116PhlebitisOFFSIDES
117PneumoniaSIDER
118PolyneuropathyOFFSIDES
119Post procedural complicationOFFSIDES
120ProctitisOFFSIDES
121ProctocolitisSIDER
122PruritusSIDER
123Pulmonary Eosinophilia21127763CTD
124Pulmonary congestionOFFSIDES
125Pulmonary thrombosisOFFSIDES
126Rectal tenesmusOFFSIDES
127Renal tubular necrosisOFFSIDES
128Respiratory FailureOFFSIDES
129RhabdomyolysisOFFSIDES
130RhinitisSIDER
131Seronegative arthritisOFFSIDES
132Skin lesionOFFSIDES
133SpondylitisOFFSIDES
134SwellingSIDER
135TachycardiaSIDER
136Therapy non-responderOFFSIDES
137Troponin I increasedOFFSIDES
138Troponin increasedOFFSIDES
139VasculitisSIDER
140VomitingSIDER
141effusionOFFSIDES
142jaundiceSIDER
143nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.